Doctoral student training program in movement disorders research receives renewal
The program trains doctoral students to become independent researchers in Parkinson’s disease, dystonia, tremor and ataxia.
Posted in
MBI News
Blood tests for Alzheimer’s explained
In The Conversation, Drs. Golde and DeKosky explain the new test, which shows high accuracy in detecting chemicals specific to Alzheimer’s.
Using electronic health records to look for new Alzheimer’s treatments through drug repurposing
Drs. Michael Jaffee and Glenn Smith are co-PIs on a UF Research Opportunity Seed Fund Award.
UF neurologists create a new image of Parkinson disease
New, more diverse image better represents who is affected by Parkinson disease, and how.
Study shows diabetes drug improves symptoms in subtype of ALS in mice
Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.
UF neuroscientists identify mechanism, potential treatment target for overexposure to manganese
New study led by Dr. Habibeh Khoshbouei, describes how impairment of dopamine transmission caused by manganese toxicity could potentially be blocked.
UF named coordinating center for national drug abuse surveillance system
Drs. Linda Cottler and Sara Jo Nixon are members of UF's coordinating center team to lead national efforts to identify emerging drug abuse trends.
Investigators earn Michael J. Fox Foundation award
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
Research Snapshot: Drs. Garrett Smith and Thomas C. Foster
New study demonstrates an example of the brain’s ability to shift and utilize different neural circuits to perform a task in order to compensate for brain aging.
Should neurologists be concerned with REM sleep quantity?
In JAMA Neurology editorial, Dr. Michael Jaffee and colleagues discuss REM sleep’s potential impact on general health.
